BURLINGTON, Vermont – June 25, 2024 – The International Academy on the Science and Impact of Cannabis (IASIC) released its official statement against the proposed rescheduling of Cannabis from Schedule I to Schedule III of the Controlled Substances Act:
As physicians and concerned citizens of the United States of America, the International Academy on the Science and Impact of Cannabis believes that re-scheduling will have immediate and irreparable harm to the public health and vehemently oppose the removal of cannabis from Schedule 1. Specific objections include (1) The Department of Health and Human Services (HHS) inappropriately changed the definition of currently acceptable medical use (CAMU); (2) Even under the new definition, cannabis still does not meet the requirements for CAMU; (3) Proper regulation of cannabis as a schedule 3 drug cannot be achieved while non-medical cannabis commerce is allowed.
“HHS and those who are pushing rescheduling of cannabis are unaware or ignoring the huge amount of science on the medical harms of cannabis. There is zero benefit and only problems to be had from rescheduling,” said Eric A. Voth, MD, FACP, President and Chairman of the Board, The International Academy on the Science and Impact of Cannabis.
An official request for a hearing with the DEA has been submitted by IASIC during the current open comment period, with its leadership urging the presentation of medical and scientific research from its physician-driven organization of international experts on cannabis.
IASIC has provided substantial education and background on the impending harm of the proposed rescheduling in its monthly speaker series on June 11th as well as on the High Truths on Drugs and Addiction podcast with episode #182: High Truths on Drugs and Addiction on Rescheduling of Marijuana with IASIC.
As the state continues to experience what Children’s Hospital has called “an emergency” in children’s mental health, I’ve been wondering why Colorado is so much worse than other states in quality and access of care, as well as rates of teen suicide and mental illness. To read more, click here for the story from The
Nonmedical (“recreational”) cannabis use and cannabis laws have changed over the past two decades in the United States (1) and the rest of the world (2). Increasing use, especially among the young, coupled with the increasing potency of cannabis (higher delta-9-tetrahydrocannabinol [THC] content) during this period (3), has raised concerns about the long-term health impact
Sir Robin Murray, a professor at King’s College London, issued stern words of warning in a new interview: has caused psychosis in around 30 percent of the patients he sees at his practice in south London. “I think we’re now 100 percent sure that cannabis is one of the causes of a schizophrenia-like psychosis,” he
Wife of a CO Senator and mother of four, Michelle Priola penned this piece for the Denver Gazette about her son’s struggles and triumph over high-potency marijuana. “Our oldest child started using high-potency marijuana at age 14. He got it from his friend’s older brother. His discovery has had a profound impact on his life
Children of women who use marijuana during or soon after pregnancy are twice as likely as other kids to become anxious, aggressive or hyperactive, according to a new study (https://www.pnas.org/content/118/47/e2106115118). The findings add weight to a growing body of evidence linking cannabis use during pregnancy to psychiatric problems in children. The study does not, however,
Since the recreational use of cannabis was legalized in California a few years ago, public attitudes in the state toward marijuana use have continued to soften. For many years, marijuana has been associated with pain relief, relaxation, and an overall mellow disposition. Proponents of legalizing the drug claim it is less dangerous than alcohol or
Nikolas Cruz, 23, convicted of murdering 17 people and injuring 17 others at Marjory Stoneman Douglas High School in 2018, recently gave a statement to the families of his victims in which he proclaimed that he “hate(s) drugs.” “I hate drugs, and I believe this country would do better if everyone would stop smoking marijuana
This statement can be made based on the Bradford Hill criteria. Visit the IASIC library to read more about the Bradford Hill criteria and various adverse effects of marijuana. People argue the difference between causation and association. This was the same argument held 100 years ago with tobacco. How can one prove that black lungs and cancer
Case Reports on the Failure of Smoking Marijuana to Prevent Relapse to Use of Opiates in Adolescents/Young Adults With Opiate Use Disorder Twenty-six adolescent/young adult patients with opioid use disorder smoked marijuana in an attempt to avoid relapse to opiate use. In each case, smoking marijuana increased cravings and urges for opiates and promoted opiate
JAMA Psychiatry just released a new longitudinal study from Denmark regarding the association of between a diagnosis of a cannabis use disorder (CUD) and a diagnosis of Schizophrenia in patients. The nationwide study, “Development Over Time of the Population-Attributable Risk Fraction for Cannabis Use Disorder in Schizophrenia in Denmark” (C. Hjorthøj et.al.) conducted an analysis
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
Exciting News! Libby Stuyt’s Interview on Randy Tobler Show! Hey everyone, we wanted to share some thrilling news! The brilliant Dr. Libby Stuyt recently had an enlightening interview on Randy Tobler Show. Dr. Stuyt is known for her groundbreaking work in the field of addiction medicine and mental health. Her insights are nothing short of
Introduction Cannabis contains over 100 cannabinoids, of which Δ9-tetrahydrocannabinol and cannabidiol are the most clinically relevant. Tetrahydrocannabinol is a partial agonist at CB1 and binds CB2 receptors. CB1 is widely expressed by central and peripheral neurones but also by immune cells and other type of cells in the brain and in the periphery, and when
The International Academy on the Science and Impact of Cannabis (IASIC) is excited to present the IASIC Speaker Series. Presented free of charge, this ongoing educational seminar series will focus on the science, data and peer-reviewed research surrounding marijuana and will be led by international medical experts. This non-partisan and non-political series is continually developed,
